[Advantage of using tumor markers in colorectal and breast cancers. Guidelines of the American Society of Clinical Oncology (ASCO)]

Bull Cancer. 1997 Jul;84(7):767-8.
[Article in French]
No abstract available

Publication types

  • Guideline
  • Practice Guideline

MeSH terms

  • Biomarkers, Tumor / blood*
  • Breast Neoplasms / blood*
  • Breast Neoplasms / pathology
  • Colorectal Neoplasms / blood*
  • Colorectal Neoplasms / pathology
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Male
  • Neoplasm Staging
  • Ploidies

Substances

  • Biomarkers, Tumor